Group B streptococcal disease in UK and Irish infants younger than 90 days

Paul T. Heath*, Gail Balfour, Abbie M. Weisner, Androulla Efstratiou, Theresa Lamagni, Helen Tighe, Liam A.F. O'Connell, Mary Cafferkey, Neville Verlander, Angus Nicoll, A. Christine McCartney

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    212 Citations (Scopus)

    Abstract

    The incidence, morbidity, and mortality of group B streptococcal disease in the UK and Republic of Ireland are largely unknown. Between Feb 1, 2000, and Feb 28, 2001, we identified cases of invasive group B streptococcal disease in infants younger than 90 days through surveillance involving paediatricians, microbiologists, and parents. 568 cases were identified, equivalent to a total incidence of 0.72 per 1000 live-births (95% CI 0.66-0.78); the incidence for early-onset disease (n=377) was 0.48 per 1000 (0.43-0.53), and for late-onset disease (n=191) was 0.24 per 1000 (0.21-0.28). Risk factors were identifiable for 218 (58%) cases of early-onset disease. 53 infants died (overall 9.7%). We have established the minimum current burden of group B streptococcal disease in UK and Irish infants. This information will assist in the formulation of guidelines for prevention of this disease.

    Original languageEnglish
    Pages (from-to)292-294
    Number of pages3
    JournalThe Lancet
    Volume363
    Issue number9405
    DOIs
    Publication statusPublished - 24 Jan 2004

    Bibliographical note

    Funding Information:
    We acknowledge Richard Lynn of the British Paediatric Surveillance Unit who coordinated initial paediatric reports; Pauline Waight for early help with microbiological reports and Chris Lane who geographically analysed reports, both from the PHLS Communicable Disease Surveillance Centre; and Jane Plumb from the Group B Strep Support charity for help with parents' reports. We thank all paediatricians, microbiologists, and parents who contributed to the study. The study was funded by a programme grant from the Meningitis Research Foundation. The sponsor had no role in study design; collection, analysis, and interpretation of data; writing of the report; or in the decision to submit the paper for publication.

    Fingerprint

    Dive into the research topics of 'Group B streptococcal disease in UK and Irish infants younger than 90 days'. Together they form a unique fingerprint.

    Cite this